✦ LIBER ✦

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy : A phase 2 study of the department of defense prostate cancer clinical trials consortium

✍ Scribed by Andrea L. Harzstark; Jonathan E. Rosenberg; Vivian K. Weinberg; Jeremy Sharib; Charles J. Ryan; David C. Smith; Lance C. Pagliaro; Tomasz M. Beer; Glenn Liu; Eric J. Small

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 206 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25810

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vorinostat in advanced prostate cancer p

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

✍ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views